PCI in the long lesion: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m (Robot: Changing Category:Up-To-Date Cardiology to Category:Up-To-Date cardiology) |
||
Line 17: | Line 17: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} | |||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
[[Category: Up-To-Date]] | [[Category:Up-To-Date]] | ||
[[Category: Up-To-Date | [[Category:Up-To-Date cardiology]] | ||
Revision as of 21:06, 22 November 2011
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Key Words and Synonyms: diffuse disease, extensive lesion, long lesion
Overview
A diffuse lesion is defined as a coronary artery lesion of greater than 20 mm in length. Resistance to coronary blood flow in a coronary vessel is not only due to the severity of a focal stenosis, but also to the length of that stenosis. Long lesions that are moderate in nature may therefore cause a significant resistance to flow.
Treatment
- A single stent that is very long should be placed to minimize stent overlap which is associated with greater risk of stent thrombosis.
- If a bare metal stent is placed, it should be remembered that the risk of restenosis proportional to the length of the bare-metal stent placed in the segment.
- There some data to suggest that glycoprotein 2b3a inhibition is of greater use in longer lesions given the greater extent of vessel injury.
Complications
Long lesions are associated with a greater plaque burden and as such are likewise associated with a greater risk of no reflow. Longer lesions are also associated with an increased risk of side branch occlusion.